Wang, Fang <br/><br/>
Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells.  [electronic resource] 

 -  Molecules (Basel, Switzerland)  Mar 2014 
 - 3356-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-3049 
<br/><br/><label>Standard No.: </label>10.3390/molecules19033356  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP-ribosyl Cyclase 1--metabolism<br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Animals<br/>Antigens, CD34--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Drug Resistance, Multiple--drug effects<br/>Drug Synergism<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Gene Expression<br/>Humans<br/>Inhibitory Concentration 50<br/>Leukemia<br/>Mice<br/>Neoplasm Proteins--genetics<br/>Neoplastic Stem Cells--drug effects<br/>Pyrimidines--pharmacology